Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

News: The Max Cure Foundation

Hiebert’s Lymphoma Research Gains Support

Friday, August 26th, 2011

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center, has received a grant from the Samuel Waxman Cancer Research Foundation (SWCRF) to study genetic mutations related to B-cell lymphoma. The grant will help launch Hiebert’s research into the cascade of mutations that lead to B-cell lymphoma. The Max Cure Foundation has agreed […]